|
 |
|
|
|
| |
|
|
|
|
| Table 8. HIV-infected patients currently prescribed highly active antiretroviral therapy (HAART) by data source and race/ethnicity |
|
|
|
|
View PDF
|
|
Data in Tables 6-8 are based on the following analyses:
- Among patients eligible according to guidelines in place in 1999, what is the proportion of patients prescribed highly active antiretroviral therapy1 (HAART) in ASD in 1999 and SHDC in 1998?
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Data Source |
Total |
|
White |
|
Black |
|
Hispanic |
|
Asian/Pacific
Islander |
|
American Indian/
Alaska Native |
| % |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
| ASD* |
61 |
5,479/8,923 |
|
63 |
1,758/2,809 |
|
59 |
2,416/4,084 |
|
64 |
1,201/1,866 |
|
66 |
62/94 |
|
55 |
26/47 |
| SHDC Site A |
68 |
166/242 |
66 |
78/118 |
71 |
48/68 |
— |
— |
— |
— |
— |
— |
| SHDC Site B |
64 |
111/171 |
70 |
51/73 |
61 |
54/89 |
— |
— |
— |
— |
— |
— |
| SHDC Site C |
69 |
161/249 |
77 |
95/123 |
68 |
75/111 |
— |
— |
— |
— |
— |
— |
|
|
|
|
*The ASD total contains 23 patients with unknown race/ethnicity |
- The proportion of eligible patients currently prescribed HAART by race/ethnicity varied from 55% among American Indians/Alaska Natives to 77% among whites.
- Similar proportions of whites compared with blacks were prescribed HAART at SHDC Site A, and a greater proportion of whites than blacks were prescribed HAART at SHDC Site B and Site C.
- Proportions were not presented for Hispanics, Asian/Pacific Islanders, and American Indian/Alaska Natives in SHDC because estimates were based on a small number of cases.
- Results for racial and ethnic groups with small numerators and/or denominators should be interpreted with caution.
- Data from the SHAS and MOPTB studies were not available for this question.
|
|
|
|
|
|
|
|
|
|
|
